NO971136D0 - Aminoalkyl- og acylaminoaklyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister - Google Patents
Aminoalkyl- og acylaminoaklyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonisterInfo
- Publication number
- NO971136D0 NO971136D0 NO971136A NO971136A NO971136D0 NO 971136 D0 NO971136 D0 NO 971136D0 NO 971136 A NO971136 A NO 971136A NO 971136 A NO971136 A NO 971136A NO 971136 D0 NO971136 D0 NO 971136D0
- Authority
- NO
- Norway
- Prior art keywords
- acylaminoaclyl
- aminoalkyl
- ether
- preparation
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19609827A DE19609827A1 (de) | 1996-03-13 | 1996-03-13 | Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971136D0 true NO971136D0 (no) | 1997-03-12 |
| NO971136L NO971136L (no) | 1997-09-15 |
Family
ID=7788139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971136A NO971136L (no) | 1996-03-13 | 1997-03-12 | Aminoalkyl- og acylaminoalkyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6140341A (no) |
| EP (1) | EP0795547B1 (no) |
| JP (1) | JP4317597B2 (no) |
| KR (1) | KR970065521A (no) |
| AR (1) | AR006189A1 (no) |
| AT (1) | ATE192738T1 (no) |
| AU (1) | AU1621797A (no) |
| BR (1) | BR9701267A (no) |
| CA (1) | CA2199771A1 (no) |
| CZ (1) | CZ76697A3 (no) |
| DE (2) | DE19609827A1 (no) |
| DK (1) | DK0795547T3 (no) |
| ES (1) | ES2148858T3 (no) |
| GR (1) | GR3033415T3 (no) |
| HR (1) | HRP970138A2 (no) |
| HU (1) | HUP9700566A1 (no) |
| ID (1) | ID16217A (no) |
| IL (1) | IL120427A0 (no) |
| NO (1) | NO971136L (no) |
| PL (1) | PL318923A1 (no) |
| PT (1) | PT795547E (no) |
| SI (1) | SI0795547T1 (no) |
| SK (1) | SK32097A3 (no) |
| TR (1) | TR199700184A2 (no) |
| TW (1) | TW363891B (no) |
| ZA (1) | ZA972129B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6376670B1 (en) | 1997-06-19 | 2002-04-23 | Sepracor Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| US6207679B1 (en) | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| KR20010014030A (ko) | 1997-06-19 | 2001-02-26 | 더글라스이.리디치 | 퀴놀린-인돌 항균제, 이들의 용도 및 조성물 |
| EP1914236A1 (en) | 2002-04-10 | 2008-04-23 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| CA2704199C (en) | 2007-11-01 | 2016-01-19 | Acucela Inc. | Amine derivative compounds for treating ophthalmic diseases and disorders |
| AR113839A1 (es) | 2017-11-24 | 2020-06-17 | Pharvaris B V | Antagonistas del receptor b2 de bradiquinina |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| RS65427B1 (sr) | 2021-08-05 | 2024-05-31 | Pharvaris Gmbh | Kompozicija na bazi lipida za oralnu primenu antagonista receptora bradikinina b2 |
| WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| WO2023180575A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5216165A (en) * | 1990-10-03 | 1993-06-01 | American Home Products Corporation | N-substituted aminoquinolines as analgesic agents |
| US5288725A (en) * | 1992-10-15 | 1994-02-22 | Merck & Co., Inc. | Pyrroloquinoline Bradykinin antagonist |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
| ES2218554T3 (es) * | 1994-10-27 | 2004-11-16 | Fujisawa Pharmaceutical Co., Ltd. | Piridopirimidonas, quinolinas y n-heterociclos condensados que son antagonistas de bradiquinina. |
| FR2735128B1 (fr) * | 1995-06-07 | 1997-07-25 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique. |
| FR2737892B1 (fr) * | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
-
1996
- 1996-03-13 DE DE19609827A patent/DE19609827A1/de not_active Withdrawn
-
1997
- 1997-02-27 DK DK97103163T patent/DK0795547T3/da active
- 1997-02-27 SI SI9730063T patent/SI0795547T1/xx unknown
- 1997-02-27 ES ES97103163T patent/ES2148858T3/es not_active Expired - Lifetime
- 1997-02-27 PT PT97103163T patent/PT795547E/pt unknown
- 1997-02-27 EP EP97103163A patent/EP0795547B1/de not_active Expired - Lifetime
- 1997-02-27 AT AT97103163T patent/ATE192738T1/de not_active IP Right Cessation
- 1997-02-27 DE DE59701617T patent/DE59701617D1/de not_active Expired - Lifetime
- 1997-03-10 ID IDP970758A patent/ID16217A/id unknown
- 1997-03-11 TW TW086102960A patent/TW363891B/zh active
- 1997-03-11 SK SK320-97A patent/SK32097A3/sk unknown
- 1997-03-11 TR TR97/00184A patent/TR199700184A2/xx unknown
- 1997-03-11 AR ARP970100968A patent/AR006189A1/es unknown
- 1997-03-11 AU AU16217/97A patent/AU1621797A/en not_active Abandoned
- 1997-03-11 HU HU9700566A patent/HUP9700566A1/hu unknown
- 1997-03-12 CZ CZ97766A patent/CZ76697A3/cs unknown
- 1997-03-12 PL PL97318923A patent/PL318923A1/xx unknown
- 1997-03-12 NO NO971136A patent/NO971136L/no unknown
- 1997-03-12 JP JP05783497A patent/JP4317597B2/ja not_active Expired - Fee Related
- 1997-03-12 US US08/820,321 patent/US6140341A/en not_active Expired - Fee Related
- 1997-03-12 BR BR9701267A patent/BR9701267A/pt unknown
- 1997-03-12 IL IL12042797A patent/IL120427A0/xx unknown
- 1997-03-12 ZA ZA9702129A patent/ZA972129B/xx unknown
- 1997-03-12 CA CA002199771A patent/CA2199771A1/en not_active Abandoned
- 1997-03-12 KR KR1019970008175A patent/KR970065521A/ko not_active Application Discontinuation
- 1997-03-12 HR HR19609827.0A patent/HRP970138A2/xx not_active Application Discontinuation
-
2000
- 2000-05-16 GR GR20000401105T patent/GR3033415T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW363891B (en) | 1999-07-11 |
| HRP970138A2 (en) | 1998-04-30 |
| DK0795547T3 (da) | 2000-09-18 |
| ID16217A (id) | 1997-09-11 |
| EP0795547A1 (de) | 1997-09-17 |
| ES2148858T3 (es) | 2000-10-16 |
| HUP9700566A1 (hu) | 2000-08-28 |
| DE19609827A1 (de) | 1997-09-18 |
| HU9700566D0 (en) | 1997-04-28 |
| JPH101472A (ja) | 1998-01-06 |
| NO971136L (no) | 1997-09-15 |
| AU1621797A (en) | 1997-09-18 |
| MX9701857A (es) | 1997-09-30 |
| JP4317597B2 (ja) | 2009-08-19 |
| TR199700184A2 (xx) | 1997-10-21 |
| SI0795547T1 (en) | 2000-10-31 |
| CA2199771A1 (en) | 1997-09-13 |
| PL318923A1 (en) | 1997-09-15 |
| PT795547E (pt) | 2000-10-31 |
| SK32097A3 (en) | 1998-01-14 |
| EP0795547B1 (de) | 2000-05-10 |
| GR3033415T3 (en) | 2000-09-29 |
| IL120427A0 (en) | 1997-07-13 |
| US6140341A (en) | 2000-10-31 |
| ZA972129B (en) | 1997-09-15 |
| AR006189A1 (es) | 1999-08-11 |
| BR9701267A (pt) | 1999-01-12 |
| CZ76697A3 (en) | 1997-10-15 |
| ATE192738T1 (de) | 2000-05-15 |
| DE59701617D1 (de) | 2000-06-15 |
| KR970065521A (ko) | 1997-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1035115T3 (da) | 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister | |
| NO990399L (no) | Substituerte pyridiner og bifenyler som anti-hyperkolesteinemiske, anti-hyperlipoproteinemiske og anti-hyperglysemiske midler | |
| IS4813A (is) | Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka | |
| HUP0201033A3 (en) | Glucagon antagonists/inverse agonists, process for their preparation and their use | |
| NO963015L (no) | Tetracykliske derivater, fremgangsmåte for fremstilling og anvendelse | |
| NO20021719D0 (no) | 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament | |
| DK0901470T3 (da) | Indolderivater egnede som endothelinreceptorantagonister | |
| NO971136D0 (no) | Aminoalkyl- og acylaminoaklyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister | |
| NO20006138L (no) | Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter | |
| NO984080D0 (no) | Nye arylglycinamid-derivater, fremgangsmÕte for fremstilling derav og blandinger som inneholder disse forbindelser | |
| HK1030939A1 (en) | Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists | |
| NO996115L (no) | Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister | |
| DK1068202T3 (da) | 1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister | |
| NO20022834L (no) | Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne | |
| EE03682B1 (et) | Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine | |
| DK0922050T3 (da) | 3-Descladinose-2,3-anhydroerythromycin-derivater | |
| ZA972328B (en) | Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use. | |
| NO20001288L (no) | Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmõte for fremstilling derav og anvendelse som legemiddel | |
| NO963331D0 (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| DK1025100T3 (da) | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf | |
| NO992976D0 (no) | Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister | |
| HK1033876A1 (en) | Use of nmda antagonists for treatment of irritablebowel syndrome. | |
| NO985972D0 (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
| TR199700729A3 (tr) | Sabit arilpirol parçaciklari, bunlarin hazirlanmasi için usul. | |
| NO990705D0 (no) | Tinndendrimerer, deres anvendelse som r°ntgenkontrastmidler og fremgangsmÕter for deres fremstilling |